AT Bancorp’s Bristol-Myers Squibb BMY Stock Holding History

AT Bancorp’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$420K	Hold	8,808	–	–	0.05%	165
2018 Q4	$458K	Hold	8,808	–	–	0.06%	156
2018 Q3	$547K	Hold	8,808	–	–	0.06%	152
2018 Q2	$487K	Buy	8,808 +330	+4%	+$17.8K	0.05%	161
2018 Q1	$536K	Buy	8,478 +350	+4%	+$22.5K	0.06%	156
2017 Q4	$498K	Hold	8,128	–	–	0.05%	164
2017 Q3	$518K	Sell	8,128 -8,078	-50%	-$472K	0.06%	154
2017 Q2	$903K	Sell	16,206 -11,289	-41%	-$614K	0.11%	104
2017 Q1	$1.5M	Buy	27,495 +18,424	+203%	+$1.01M	0.19%	98
2016 Q4	$530K	Buy	9,071 +697	+8%	+$38.1K	0.07%	201
2016 Q3	$452K	Buy	8,374 +609	+8%	+$39.1K	0.06%	203
2016 Q2	$571K	Hold	7,765	–	–	0.08%	169
2016 Q1	$496K	Hold	7,765	–	–	0.07%	169
2015 Q4	$534K	Sell	7,765 -101	-1%	-$6.67K	0.15%	133
2015 Q3	$466K	Buy	7,866 +135	+2%	+$8.56K	0.14%	133
2015 Q2	$514K	Hold	7,731	–	–	0.13%	140
2015 Q1	$499K	Sell	7,731 -502	-6%	-$31.4K	0.14%	143
2014 Q4	$486K	Buy	8,233 +352	+4%	+$19.9K	0.14%	134
2014 Q3	$403K	Sell	7,881 -292	-4%	-$14.6K	0.12%	145
2014 Q2	$396K	Buy	8,173 +266	+3%	+$13.1K	0.12%	138
2014 Q1	$411K	Buy	7,907 +26	+0.3%	+$1.38K	0.13%	129
2013 Q4	$419K	Sell	7,881 -3,903	-33%	-$199K	0.13%	117
2013 Q3	$545K	Sell	11,784 -831	-7%	-$36.5K	0.19%	105
2013 Q2	$564K	Buy	+12,615	New	+$548K	0.2%	116

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

AT Bancorp's BMY Position: Q1 2019 in Review

AT Bancorp held its Bristol-Myers Squibb (BMY) position steady in Q1 2019 at 8,808 shares worth $420K. The position accounts for 0.05% of the portfolio, ranked #165.

AT Bancorp first reported a position in BMY in Q2 2013 and has held it in 24 quarters since. The position peaked at $1.5M in Q1 2017. 1,813 funds tracked by Wall St. Rank hold BMY as of Q1 2019.

AT Bancorp held 8,808 shares of Bristol-Myers Squibb worth $420K as of Q1 2019.
AT Bancorp left its Bristol-Myers Squibb share count unchanged in Q1 2019.
Bristol-Myers Squibb made up 0.05% of AT Bancorp's portfolio in Q1 2019, its #165 holding.
AT Bancorp first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 24 quarters since.
AT Bancorp's Bristol-Myers Squibb position peaked at $1.5M in Q1 2017.
1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2019.

Based on AT Bancorp's 13F filing for Q1 2019, filed 13 May 2019.